Tyrosine kinase signalling in breast cancer fibroblast growth factors and their receptors

Breast Cancer Research

Volumn 2, Issue 3, 2000, Pages 191-196

  Dickson, C ^a   Spencer Dene, B ^a   Dillon, C ^a   Fantl, V ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Breast cancer; Fibroblast growth factor; Mammary; Receptor

Indexed keywords

CELL SURFACE RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR; LIGAND; TYROSINE KINASE RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST EPITHELIUM; CELL DIFFERENTIATION; DEVELOPMENT; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOGENICITY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; PROVIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; MICE; ONCOGENES; PROTEIN-TYROSINE KINASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0034467004     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr53     Document Type: Review

References (61)

1. The FGF family of growth-factors and oncogenes
2. Structural and functional diversity in the FGF receptor multigene family
3. The heparan-sulfate fibroblast growth-factor family: Diversity of structure and function
4. Signal transduction by fibroblast growth factor receptors
5. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor
6. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species
7. Synaptotagmin-1 is required for fibroblast growth-factor-1 release
8. +-ATPase
9. The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock
10. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH3T3 cells
11. A dual receptor system is required for basic fibroblast growth factor activity
12. Receptor specificity of the fibroblast growth-factor family
13. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse
14. Developmental localization of the splicing alternatives of fibroblast growth-factor receptor-2 (FGFR2)
15. Unique expression pattern of the fgf receptor-3 gene during mouse organogenesis
16. A novel endothelial-cell surface-receptor tyrosine kinase with extracellular epidermal growth-factor homology domains
17. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse
18. Structural basis of fgf receptor dimerization and activation
19. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds
20. Fibroblast growth-factors in mammalian development
21. The roles of FGFs in the early development of vertebrate limbs
22. An FGF receptor signaling pathway is required for the normal-cell migrations of the sex myoblasts in C-elegans hermaphrodites
23. The Drosophila FGF-R homolog is expressed in the embryonic tracheal system and appears to be required for directed tracheal cell extension
24. Skeletal disorders associated with fibroblast growth-factor receptor mutations
25. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
26. A new nomenclature for int-1 and related genes: The Wnt gene family
27. Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors
28. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus
29. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors
30. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants
31. The int-2 gene product acts as an epithelial growth factor in transgenic mice
32. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
33. Transgenes expressing the wnt-1 and int-2 protooncogenes cooperate during mammary carcinogenesis in doubly transgenic mice
34. Mouse mammary-tumor virus-infection accelerates mammary carcinogenesis in wnt-1 transgenic mice by insertional activation of int-2/fgf-3 and hst/fgf-4
35. FGF-8, activated by proviral insertion, cooperates with the wnt-1 transgene in murine mammary tumorigenesis
36. Chromosome 11q13 abnormalities in human cancer
37. Expression of FGF and FGF receptor genes in human breast-cancer
38. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth pleiotrophin in human primary breast cancer and its relation to angiogenesis
39. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival
40. Low levels of basic fibroblast growth factor (bFGF) are associated with a poor pronosis in human breast carcinoma
41. Comparative expression of fibroblast growth-factor messenger-RNAs in benign and malignant breast disease
42. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
43. Fibroblast growth factor-2 in breast cancer occurrence and prognostic significance
44. Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma
45. Acidic and basic fibroblast growth-factors in human breast-tissue
46. Expression of fibroblast growth-factor-1 is lower in breast-cancer than in the normal human breast
47. The location of acidic fibroblast growth-factor in the breast is dependent on the activity of proteases present in breast-cancer tissue
48. Increased expression of fibroblast growth factor 8 in human breast cancer
49. High-frequency of fibroblast-growth-factor (FGF)-8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal-antibody against FGF-8
50. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers
51. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers
52. Basic fibroblast-growth-factor receptors and their prognostic value in human breast-cancer
53. Frequent activating mutations of FGFR3 in human bladder and cervix carcinoma
54. Ligand-independent activation of fibroblast growth-factor receptors by point mutations in the extracellular, transmembrane, and kinase domains
55. Graded activation of fibroblast growth-factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
56. Constitutive activation of fibroblast growth-factor receptor-3 by the transmembrane domain point mutation found in achondroplasia
57. Fibroblast growth-factor receptor signaling has a role in lobuloalveolar development of the mammary-gland
58. Insertional mutagenesis identifies a member of the wnt gene family as a candidate oncogene in the mammary epithelium of int-2/FGF-3 transgenic mice
59. A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17
60. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and activated by proviral insertion in some virally induced mammary tumors
61. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/wnt-1 and is normally expressed in mouse embryos and adult brain